Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

18.06.2024 / 09:52 CET/CEST
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Ulrich
Last name(s): Köstlin

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Newron Pharmaceuticals S.p.A.

b) LEI
8156002F8C11F80A9740 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: IT0004147952

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
9.8 CHF 12955.6 CHF
9.8 CHF 9800 CHF
9.8 CHF 4900 CHF
9.8 CHF 1009.4 CHF

d) Aggregated information
Price Aggregated volume
9.8000 CHF 28665.0000 CHF

e) Date of the transaction
17/06/2024; UTC+2

f) Place of the transaction
Name: SIX Swiss Exchange
MIC: XSWX



18.06.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Newron Pharmaceuticals S.p.A.
via Antonio Meucci 3
20091 Bresso
Italy
Internet: www.newron.com

 
End of News EQS News Service

92487  18.06.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1927575&application_name=news&site_id=zonebourse_com~~~71435185-72e2-4ff3-98c0-1866a1714c4a